𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Predictive factors affecting early deterioration of axial symptoms after subthalamic nucleus stimulation in Parkinson’s disease

✍ Scribed by Atsushi Umemura; Yuichi Oka; Kenji Okita; Takanari Toyoda; Noriyuki Matsukawa; Kazuo Yamada

Book ID
116820820
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
105 KB
Volume
16
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ten-Hertz stimulation of subthalamic nuc
Ten-Hertz stimulation of subthalamic nucleus deteriorates motor symptoms in Parkinson's disease
✍ Lars Timmermann; Lars Wojtecki; Joachim Gross; Ralph Lehrke; Jürgen Voges; Moham 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Abstract Recently, a pathological oscillatory network at 10 Hz including several motor areas was described in patients with idiopathic Parkinson's disease (PD). In 7 PD patients, we tested the clinical effect of subthalamic nucleus (STN) stimulation at varying frequencies 1 to 3 years after impl

Postoperative gait deterioration after b
Postoperative gait deterioration after bilateral subthalamic nucleus stimulation in Parkinson's disease
✍ Bart F.L. van Nuenen; Rianne A.J. Esselink; Marten Munneke; Johhannes D. Speelma 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

## Abstract Deep brain stimulation of the subthalamic nuclei (STN) is a good therapeutic option to reduce dyskinesias and improve appendicular motor signs in well‐selected patients with advanced Parkinson's disease (PD). Concerns about long‐term adverse effects play an increasingly role in the deci

Risk factors for executive dysfunction a
Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease
✍ Christine Daniels; Paul Krack; Jens Volkmann; Markus O. Pinsker; Martin Krause; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

## Abstract A slight decline in cognitive functions and especially in executive functioning after deep brain stimulation (DBS) of the nucleus subthalamicus (STN) in patients with Parkinson's disease (PD) has been described. This study evaluated baseline parameters that contribute to a deterioration